Evaluation of the effect of the carrier of polymorphic variants of the SLCO1B1 gene on efficacy and safety in patients during treatment with statins
The number of patients receiving statins is increasing every year. Considering the need for life-long intake of drugs of this group, the problem of improving safety and efficacy of their use becomes especially important. There is a large amount of data on the influence of various genetic factors on...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
| Serija: | Безопасность и риск фармакотерапии |
| Teme: | |
| Online dostop: | https://www.risksafety.ru/jour/article/view/87 |
| Oznake: |
Brez oznak, prvi označite!
|